Sign in Subscribe
Epidemics

Experimental Vaccine Shows Encouraging Results, Nursing Home COVID-19 Testing Plan Criticized

Strategic Insights

— 1 min read

Preliminary trials of an experimental coronavirus vaccine showed promising results, with high levels of antibodies against COVID-19 and no adverse side effects. Meanwhile, the Trump administration's plan to provide fast COVID-19 testing machines to nursing homes has been criticized for its limitations, as the government will only provide test kits for residents once and staff twice, and nursing homes may be forced to cover the significant costs of testing employees.

Key Takeaways:

  • Preliminary trials of an experimental coronavirus vaccine showed encouraging results, with 56 people producing high levels of antibodies against COVID-19 with no adverse side effects.
  • The vaccine also protected monkeys from COVID-19 infection in a second study.
  • The vaccine has the potential to produce 100 million doses by the beginning of 2021, enough to inoculate 50 million people with the required two doses.
  • The Trump administration's plan to provide fast COVID-19 testing machines to nursing homes has been criticized for its limitations, including only providing test kits for residents once and staff twice.
  • Nursing homes may be forced to cover the significant costs of testing employees, which could range from $19,000 to nearly $38,000 a week.

Statistics:

  • 56 people produced high levels of antibodies against COVID-19 with no adverse side effects in preliminary trials of the experimental coronavirus vaccine.
  • The vaccine protected monkeys from COVID-19 infection in a second study.
  • The vaccine has the potential to produce 100 million doses by the beginning of 2021.
  • Nursing homes contain 15,400 facilities in the United States.
  • The Centers for Medicare and Medicaid Services estimate that it could take 14 weeks to deliver a testing machine to every nursing home.
  • The Trump administration hopes to deliver 2,400 fast-test machines and hundreds of thousands of test kits by mid-August under the testing plan.

Sources:

  • Associated Press: "Tests of Trump's Nursing Home Testing Plan Raise Questions"
  • The New York Times: "Experimental Coronavirus Vaccine Shows Promising Results in Early Trials"
  • HealthDay: "Experimental Vaccine Shows Encouraging Results"
  • Thomson International Inc.: Recall notice and statement on tainted onions
  • Weill Cornell Medicine: Interview with John Moore, virologist
  • Columbia University: Interview with Angela Rasmussen, virologist

Read more